These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20185316)

  • 1. Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Prado-Prado FJ; García-Mera X; González-Díaz H
    Bioorg Med Chem; 2010 Mar; 18(6):2225-2231. PubMed ID: 20185316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.
    Prado-Prado FJ; González-Díaz H; de la Vega OM; Ubeira FM; Chou KC
    Bioorg Med Chem; 2008 Jun; 16(11):5871-80. PubMed ID: 18485714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-target spectral moment: QSAR for antiviral drugs vs. different viral species.
    Prado-Prado FJ; Borges F; Uriarte E; Peréz-Montoto LG; González-Díaz H
    Anal Chim Acta; 2009 Oct; 651(2):159-64. PubMed ID: 19782806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-target spectral moment: QSAR for antifungal drugs vs. different fungi species.
    Prado-Prado FJ; Borges F; Perez-Montoto LG; González-Díaz H
    Eur J Med Chem; 2009 Oct; 44(10):4051-6. PubMed ID: 19467743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unified QSAR & network-based computational chemistry approach to antimicrobials. II. Multiple distance and triadic census analysis of antiparasitic drugs complex networks.
    Prado-Prado FJ; Ubeira FM; Borges F; González-Díaz H
    J Comput Chem; 2010 Jan; 31(1):164-73. PubMed ID: 19421992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
    Prado-Prado FJ; Martinez de la Vega O; Uriarte E; Ubeira FM; Chou KC; González-Díaz H
    Bioorg Med Chem; 2009 Jan; 17(2):569-75. PubMed ID: 19112024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-target spectral moments for QSAR and Complex Networks study of antibacterial drugs.
    Prado-Prado FJ; Uriarte E; Borges F; González-Díaz H
    Eur J Med Chem; 2009 Nov; 44(11):4516-21. PubMed ID: 19631422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting drugs and proteins in parasite infections with topological indices of complex networks: theoretical backgrounds, applications, and legal issues.
    González-Díaz H; Romaris F; Duardo-Sanchez A; Pérez-Montoto LG; Prado-Prado F; Patlewicz G; Ubeira FM
    Curr Pharm Des; 2010; 16(24):2737-64. PubMed ID: 20642428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NL MIND-BEST: a web server for ligands and proteins discovery--theoretic-experimental study of proteins of Giardia lamblia and new compounds active against Plasmodium falciparum.
    González-Díaz H; Prado-Prado F; Sobarzo-Sánchez E; Haddad M; Maurel Chevalley S; Valentin A; Quetin-Leclercq J; Dea-Ayuela MA; Teresa Gomez-Muños M; Munteanu CR; José Torres-Labandeira J; García-Mera X; Tapia RA; Ubeira FM
    J Theor Biol; 2011 May; 276(1):229-49. PubMed ID: 21277861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using entropy of drug and protein graphs to predict FDA drug-target network: theoretic-experimental study of MAO inhibitors and hemoglobin peptides from Fasciola hepatica.
    Prado-Prado F; García-Mera X; Abeijón P; Alonso N; Caamaño O; Yáñez M; Gárate T; Mezo M; González-Warleta M; Muiño L; Ubeira FM; González-Díaz H
    Eur J Med Chem; 2011 Apr; 46(4):1074-94. PubMed ID: 21315497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unified QSAR approach to antimicrobials. Part 2: predicting activity against more than 90 different species in order to halt antibacterial resistance.
    Prado-Prado FJ; González-Díaz H; Santana L; Uriarte E
    Bioorg Med Chem; 2007 Jan; 15(2):897-902. PubMed ID: 17084086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unify QSAR approach to antimicrobials. Part 1: predicting antifungal activity against different species.
    González-Díaz H; Prado-Prado FJ; Santana L; Uriarte E
    Bioorg Med Chem; 2006 Sep; 14(17):5973-80. PubMed ID: 16759868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2D MI-DRAGON: a new predictor for protein-ligands interactions and theoretic-experimental studies of US FDA drug-target network, oxoisoaporphine inhibitors for MAO-A and human parasite proteins.
    Prado-Prado F; García-Mera X; Escobar M; Sobarzo-Sánchez E; Yañez M; Riera-Fernandez P; González-Díaz H
    Eur J Med Chem; 2011 Dec; 46(12):5838-51. PubMed ID: 22005185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MIND-BEST: Web server for drugs and target discovery; design, synthesis, and assay of MAO-B inhibitors and theoretical-experimental study of G3PDH protein from Trichomonas gallinae.
    González-Díaz H; Prado-Prado F; García-Mera X; Alonso N; Abeijón P; Caamaño O; Yáñez M; Munteanu CR; Pazos A; Dea-Ayuela MA; Gómez-Muñoz MT; Garijo MM; Sansano J; Ubeira FM
    J Proteome Res; 2011 Apr; 10(4):1698-718. PubMed ID: 21184613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D MI-DRAGON: new model for the reconstruction of US FDA drug- target network and theoretical-experimental studies of inhibitors of rasagiline derivatives for AChE.
    Prado-Prado F; García-Mera X; Escobar M; Alonso N; Caamaño O; Yañez M; González-Díaz H
    Curr Top Med Chem; 2012; 12(16):1843-65. PubMed ID: 23030618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theoretical study of GSK-3α: neural networks QSAR studies for the design of new inhibitors using 2D descriptors.
    García I; Fall Y; García-Mera X; Prado-Prado F
    Mol Divers; 2011 Nov; 15(4):947-55. PubMed ID: 21735119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First computational chemistry multi-target model for anti-Alzheimer, anti-parasitic, anti-fungi, and anti-bacterial activity of GSK-3 inhibitors in vitro, in vivo, and in different cellular lines.
    García I; Fall Y; Gómez G; González-Díaz H
    Mol Divers; 2011 May; 15(2):561-7. PubMed ID: 20931280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational drug design for anti-cancer chemotherapy: multi-target QSAR models for the in silico discovery of anti-colorectal cancer agents.
    Speck-Planche A; Kleandrova VV; Luan F; Cordeiro MN
    Bioorg Med Chem; 2012 Aug; 20(15):4848-55. PubMed ID: 22750007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scoring function for DNA-drug docking of anticancer and antiparasitic compounds based on spectral moments of 2D lattice graphs for molecular dynamics trajectories.
    Pérez-Montoto LG; Santana L; González-Díaz H
    Eur J Med Chem; 2009 Nov; 44(11):4461-9. PubMed ID: 19604606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From QSAR models of drugs to complex networks: state-of-art review and introduction of new Markov-spectral moments indices.
    Riera-Fernández P; Martín-Romalde R; Prado-Prado FJ; Escobar M; Munteanu CR; Concu R; Duardo-Sanchez A; González-Díaz H
    Curr Top Med Chem; 2012; 12(8):927-60. PubMed ID: 22352918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.